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Abstract
Background: Secretion of anti-host proteins by Yersinia pestis via a type III mechanism is not
constitutive. The process is tightly regulated and secretion occurs only after an appropriate signal
is received. The interaction of LcrG and LcrV has been demonstrated to play a pivotal role in
secretion control. Previous work has shown that when LcrG is incapable of interacting with LcrV,
secretion of anti-host proteins is prevented. Therefore, an understanding of how LcrG interacts
with LcrV is required to evaluate how this interaction regulates the type III secretion system of Y.
pestis. Additionally, information about structure-function relationships within LcrG is necessary to
fully understand the role of this key regulatory protein.
Results: In this study we demonstrate that the N-terminus of LcrG is required for interaction with
LcrV. The interaction likely occurs within a predicted amphipathic coiled-coil domain within LcrG.
Our results demonstrate that the hydrophobic face of the putative helix is required for LcrV
interaction. Additionally, we demonstrate that the LcrG homolog, PcrG, is incapable of blocking
type III secretion in Y. pestis. A genetic selection was utilized to obtain a PcrG variant capable of
blocking secretion. This PcrG variant allowed us to locate a region of LcrG involved in secretion
blocking.
Conclusion: Our results demonstrate that LcrG interacts with LcrV via hydrophobic interactions
located in the N-terminus of LcrG within a predicted coiled-coil motif. We also obtained
preliminary evidence that the secretion blocking activity of LcrG is located between amino acids 39
and 53.
Background
Yersinia pestis, the causative agent of bubonic plague, har-
bors a large virulence plasmid that is essential for patho-
genicity. This plasmid, called pCD1 [1] in Y. pestis,
encodes for a type III secretion apparatus necessary for the
translocation of effector proteins (Yops) into eukaryotic
target cells [2]. The net result of this polarized toxin trans-
location is the disruption of eukaryotic cell signalling and
structure [2]. Induction of the virulence-related genes on
pCD1 is linked to an in vitro phenomenon termed the
Low Calcium Response (LCR). The LCR is believed to
mimic the response of Y. pestis in contact with eukaryotic
cells when calcium ions are removed from the growth me-
dium at 37°C. The result of this in vitro induction of viru-
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lence genes is the massive secretion of Yops into the
growth medium, accompanied by a characteristic growth
restriction that is a hallmark phenotype of the LCR [3].
Secretion of Yops by the type III secretion system is not
constitutive. Control of secretion is complex and involves
several proteins that positively and negatively regulate the
activity of the secretion apparatus in response to environ-
mental conditions [3]. LcrG has been implicated in block-
ing the secretion apparatus either directly or indirectly [4],
as strains lacking lcrG constitutively secrete Yops [5], re-
gardless of inducing conditions. In addition, YopN, TyeA,
SycN, YscB, LcrH, YopD, and LcrQ are all also required for
the negative regulation of Yops secretion [6–17]. LcrV (the
V antigen) is thought to positively regulate Yops secretion
as lcrV strains do not secrete Yops, even under conditions
that normally favor secretion [18,19].
LcrG and LcrV have been demonstrated to physically in-
teract in the bacterial cytoplasm [4]. Disruption of the
LcrG-LcrV interaction or overexpression of LcrG in a low-
LcrV background both result in a constitutive blockage of
Yops secretion [18,20]. This evidence led to a model of
how these two proteins may control Yops secretion. The
LcrG-titration model theorizes that LcrG blocks the secre-
tion apparatus (Ysc) from the bacterial cytoplasm and that
interaction with LcrV is required to relieve the blockage.
Upon induction by eukaryotic cell contact or removal of
calcium from the growth medium, the intracellular level
of LcrV becomes elevated relative to that of LcrG. The in-
creased amount of LcrV removes LcrG from its secretion-
blocking role, resulting in full induction of the LCR and
secretion of Yops. Evidence accumulated to date clearly
demonstrates that the LcrG-LcrV interaction is critical for
the regulation of this complex virulence system [18,20].
Therefore, dissection of the LcrG-LcrV interaction is war-
ranted.
Utilizing yeast two-hybrid analyses, we further investigat-
ed the LcrG-LcrV interaction. We determined that the N-
terminus of LcrG is essential for LcrV interaction. The
smallest linear region of LcrG required for the interaction
is predicted to form a coiled-coil motif, a structure often
associated with protein-protein interactions. We used
both alanine-scanning and a 'radical' site-directed muta-
genesis strategy to identify amino acids critical for the in-
teraction within this region of LcrG. While alanine
mutants failed to disrupt the LcrG-LcrV interaction, radi-
cal mutations of three residues revealed a region impor-
tant for the interaction. These residues are likely to reside
on the same face of the protein if a coiled-coil structure is
assumed. Based on this evidence, we predict that the inter-
action of LcrG with LcrV occurs within an N-terminal
coiled-coil domain of LcrG via hydrophobic interactions.
Additionally, we investigated whether the Pseudomonas
homolog of LcrG, PcrG, could transcomplement an lcrG
strain of Y. pestis. The opportunistic pathogen Pseu-
domonas aeruginosa utilizes a type III secretion system for
intracellular delivery of toxins [21–23] that is the most
similar to the Yersinia system [21]. Several components of
the Pseudomonas system have been demonstrated to func-
tionally complement genetic defects in the Yersinia ho-
mologs including the LcrV homolog, PcrV [24,25].
Homologs of LcrG and LcrV (i.e., PcrG and PcrV) have
only been identified in P. aeruginosa, suggesting that this
pair of regulatory proteins may fulfill similar roles in these
extracellular pathogens. In the present study, we found
that PcrG could not substitute for LcrG, although both
proteins interacted with LcrV. This result led to a genetic
selection for PcrG variants that could transcomplement an
lcrG defect. Isolation of a PcrG variant that could substi-
tute for LcrG led to the identification of a region within
LcrG that may be involved in blocking the activity of the
Y. pestis type III secretion system.
Results and Discussion
Delineation of the LcrV-interaction domain of LcrG
LcrG and LcrV physically interact in Y. pestis [4], and that
interaction plays a significant role in the regulation of
Yops secretion [20]. LcrG and LcrV interact in a yeast two-
hybrid assay [20], therefore this technique was used to
further investigate the region of LcrG required for its inter-
action with LcrV. Truncations of LcrG were constructed
and fused to the GAL4 activation domain of pACT2. These
plasmids were co-transformed into yeast strain Y187 with
full-length LcrV fused to the GAL4 DNA binding domain
of plasmid pAS2-1 to determine if the LcrG truncations
could continue to participate in an interaction with LcrV.
Using a filter-lift assay as a qualitative determination of an
interaction and a liquid β -galactosidase assay to quantify
the results, we found that the LcrV-interaction domain of
LcrG lies in the N-terminus of the protein. The smallest
linear region of LcrG that was still capable of interacting
with LcrV was determined to be amino acids 7–40 (Fig. 1;
shown highlighted in yellow in Fig. 2). Deletion of five
additional amino acids from the N-terminus of the 7–40
construct or seven amino acids from the C-terminus of the
7–40 construct eliminated our ability to detect an interac-
tion using this system (Fig. 1). Interestingly, this approxi-
mate region of LcrG (amino acids 7–35) is predicted to
form a coiled-coil domain when LcrG is analyzed using
the COILS algorithm [26] (data not shown). These results
suggest that the LcrG-LcrV interaction requires the N-ter-
minus of LcrG and may involve a coiled-coil domain.
Alanine-scanning mutagenesis of the LcrG N-terminus
To determine individual residues of LcrG required for in-
teraction with LcrV, a systematic site-directed mutagenesis
strategy was used to change conserved or charged residuesBMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/16
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within the delineated interaction region. Initially,
alanine-scanning mutagenesis was used for this study as
alanine substitutions are generally thought to minimally
effect protein folding [27]. Sequence conservation from
the alignment of LcrG with the Pseudomonas aeruginosa
homolog, PcrG (Fig. 2), allowed the targeting of specific
residues likely to be important for the interaction. After
construction of specific missense mutants, each full-
length LcrG alanine variant was screened for interaction
with LcrV using the yeast two-hybrid assay. Surprisingly,
the alanine-scanning mutagenesis results failed to demon-
strate amino acids of LcrG involved in the LcrG-LcrV inter-
action. All of the alanine mutants screened were capable
of interaction with LcrV as demonstrated in a filter-lift as-
say. Liquid β -galactosidase assays showed that the
strength of the interactions were not significantly reduced
from that of wild-type LcrG (Table 1). These results
showed that single alanine substitutions are insufficient
to disrupt the LcrG-LcrV interaction. A likely explanation
for the failure of alanine-scanning to reveal residues in
LcrG important for LcrV interaction is that alanine is a res-
idue capable of interaction with hydrophobic residues.
Our subsequent studies suggest that the interaction of
LcrG with LcrV occurs at a hydrophobic patch within
LcrG.
'Radical' site-directed mutagenesis of LcrG allows the 
LcrG-LcrV interaction to be disrupted
Based on our experience with the alanine-scanning com-
bined with the similar results of Francis et. al [28], it
seemed likely that the LcrG-LcrV interaction was occurring
between hydrophobic residues. Accordingly, we contin-
ued to examine the interaction domain using a mutagen-
esis strategy described by Francis, et al. termed 'radical'
site-directed mutagenesis [28]. This method involves re-
placing hydrophobic residues with charged residues, or
changing charged residues to oppositely charged residues.
This method was used to mutagenize several conserved
residues in the interacting region in the effort to disrupt
the LcrG-LcrV interaction (Table 2). These 'radical' site-di-
rected mutants were then screened using the yeast two-hy-
brid system for their interaction with LcrV. Radical
mutagenesis revealed several residues with decreased β -
galactosidase activity in the yeast two hybrid system. The
LcrG mutants A16R, A16D, S23R, and L30R all had signif-
icantly decreased activity when assayed for β -galactosidase
expression (Table 2). LcrG mutants I20R, A27E, and I37R
demonstrated somewhat decreased activity (Table 2).
These results suggested that residues A16, S23, and L30
(red asterisks in Fig. 2) all participate in the interaction of
LcrG with LcrV and that residues I20, A27, and I37 may
also contribute to the interaction. Of the residues identi-
fied in these experiments, only changes to A16, S23, and
L30 were detected with a more sensitive filter-lift assay for
β -galactosidase activity and were therefore chosen for fur-
ther characterization.
The alanine at position 16 was previously identified as a
critical residue in the LcrG-LcrV interaction [20]. Two mu-
tations were characterized at this position (A16R and
Figure 1
Schematic representation of LcrG truncations fused to the GAL4 activation domain of plasmid pACT2. All con-
structs were cotransformed with full-length LcrV cloned into cyh2-deleted pAS2-1 to produce a GAL4-DNA binding domain-
LcrV chimera in S. cerevisiae strain Y187. The ability of each truncation to bind LcrV was determined qualitatively by X-gal
hydrolysis from filter-lift assays and quantitatively by the level of β -galactosidase activity expressed as Miller units in yeast liquid
cultures. Final β -galactosidase activities are calculated from the average of at least four independent measurements.
LcrG + 68.05   2.96
1-70 + 44.00   1.61
34-95 -   2.60   0.30
1-40 + 64.67   1.50
34-70 -   6.63   1.95
64-95 -   3.55   0.35
1-33 -   8.94   1.09
7-40 + 61.71   3.11
12-40 -   8.48   1.53
Filter
  lift
Miller
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A16D) and they failed to interact with LcrV, showing that
single substitutions of this kind can disrupt the LcrG-LcrV
interaction [20]. Additional data from this study showed
that a substitution of the leucine at position 30 with an ar-
ginine also prevented the LcrG-LcrV interaction in yeast
(Table 2). Interestingly, when L30 is replaced with alanine
(Table 1) or threonine (Table 2), the interaction is not ef-
fected. Mutagenesis of the serine at position 23 to arginine
resulted in an LcrG variant that weakly interacted with
LcrV as determined by a filter-lift assay for β -galactosidase
activity. The color change of the yeast colonies due to the
hydrolysis of 5-bromo-4-chloro-3-indolyl-β -D-galacto-
pyranoside (X-gal) by β -galactosidase was significantly de-
layed and less intense than the reaction we observed for
strongly interacting mutants. The liquid β -galactosidase
assay confirmed that the strength of the LcrG S23R-LcrV
interaction was reduced (Table 2), indicating that this res-
idue is likely involved in the interaction of LcrG with LcrV.
As coiled-coil motifs show a characteristic seven amino
acid repeat pattern, with each repeat representing two
turns of the α -helix, it is interesting that three positions
identified as important to the LcrG-LcrV interaction (16,
23, and 30) are each separated by seven amino acids.
When this region was analyzed using a helical wheel pro-
jection, the three residues fall on the same face of the he-
lix, which appears to be largely hydrophobic in nature
(Fig. 3). These results and observations further indicate
that the LcrG-LcrV interaction may require the participa-
tion of a coiled-coil motif and occurs at a largely hydro-
phobic interface.
To evaluate the biological significance of the changes in
interaction seen in the yeast two-hybrid system between
LcrV and LcrG S23R or LcrG L30R, LcrG S23R and L30R
were expressed in lcrG Y. pestis where their ability to con-
trol Yops secretion was examined. Neither the S23R or the
L30R mutant displayed the calcium-independent growth
phenotype previously observed for LcrG A16R [20]. LcrG
S23R displayed a wildtype growth and secretion pheno-
type while LcrG L30R was Ca2+-blind (data not shown).
To further understand the phenotypes obtained, the abil-
ity of LcrG S23R and L30R to interact with LcrV was exam-
ined in Y. pestis. Wild type LcrG, LcrG S23R, LcrG L30R,
and LcrG A16R were independently co-expressed with
His6-tagged LcrV in a strain of Y. pestis deleted for lcrGV.
The cells were French pressed and the cleared lysates were
applied to Talon columns to purify His6-tagged LcrV. As
previously reported [20], LcrG copurified with LcrV and
LcrG A16R did not copurify with LcrV (Fig. 4, lanes 3 and
12). When LcrG S23R was coexpressed with His6-tagged
LcrV, a small amount was recovered in the elution fraction
from the column (Fig. 4, lane 6). This result is indicative
of a weaker interaction between LcrG S23R and LcrV than
the interaction between wildtype LcrG and LcrV. The
weaker interaction seen in Y. pestis between LcrG S23R
and LcrV corresponds with our yeast two-hybrid data for
the S23R mutant, which showed an interaction with LcrV,
and suggests an interaction with decreased affinity (Table
2). The interaction results for LcrG S23R provide an expla-
nation for the failure of LcrG S23R to confer a Ca2+-inde-
pendent phenotype like the previously described LcrG
A16R mutant. LcrG S23R still interacts with LcrV and
therefore LcrV can neutralize the LcrG-mediated secretion
block. In fact, this result is consistent with the fact that
very low levels of LcrG are required to provide LcrG func-
tion [20]. LcrG L30R either interacts weakly with or does
not interact with His6-tagged LcrV in Y. pestis (Fig. 4, lane
9). This result also corresponds with the lack of interac-
tion observed in the yeast two-hybrid assay for this mu-
tant. Taken together, these results suggest that the residues
Figure 2
Pairwise BLAST alignment of LcrG and PcrG. Amino acid sequence alignment of LcrG from Y. pestis (NCBI RefSeq,
NP_395166;  [http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=16082720&dopt=Gen-
Pept]) and PcrG from P. aeruginosa (NCBI RefSeq, NP_250396;  [http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=
Retrieve&db =protein&list_uids=15596902&dopt=GenPept]). Overall the two proteins are 43% identical and 56% similar. The
sequences were aligned using the BLAST algorithm as implemented for pairwise alignments [37]. The region highlighted in yel-
low (amino acids 7–40) is the smallest region identified that interacts with LcrV. The region in blue (amino acids 39–53) corre-
sponds to a previously described deletion that eliminated secretion blocking activity [5]. The amino acids identified with red
asterisks are residues identified as participating in the LcrG-LcrV interaction (A16, S23, and L30). The residue marked with the
blue asterisk (F48) is required for secretion blocking activity of LcrG.
LcrG:  7 DEYDKTLKQAELAIADSDHRAKLLQEMCADIGLTPEAVMKIFAGRSAEEIKPAERELLDE 66
         D    T++ AELAI DS+ R +LL EM   +G   +A   +F     E  + AE ELL E
PcrG: 10 DTLRATVQAAELAIRDSEERGRLLAEMWQGLGFAADAGELLFQAPERELARAAEEELLAE 69
LcrG: 67 IKRQRERQPQHPYDGKRPRKPTMMRGQII 95
         ++R R  QP     G RPR+PT MRG +I
PcrG: 70 LRRMRSSQPTQGEQGTRPRRPTPMRGLLI 98
** *  *BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/16
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found to be involved in the LcrG-LcrV interaction using
two-hybrid analysis are relevant in the bacterial cell. How-
ever, the inability of L30R to function like our previously
described A16R mutant was somewhat surprising. One ex-
planation is that the protein with the L30R change is sim-
ply misfolded. The second explanation is that the
secretion-blocking and the LcrV-interaction domains of
LcrG overlap. Currently we do not possess the data re-
quired to differentiate between the two possibilities and
we are pursuing the reasons for the failure of L30R to func-
tion like wildtype LcrG.
PcrG does not complement an lcrG strain, but interacts 
with LcrV
Because the residues of LcrG required for interaction with
LcrV are strongly conserved in PcrG of P. aeruginosa (red
asterisks in Fig. 2), we determined if PcrG could interact
directly with LcrV. First, PcrG-GAL4-AD and LcrV-GAL4-
BD chimeras were coexpressed in a yeast two-hybrid as-
say. Activation of β -galactosidase by the chimeric proteins
was demonstrated by a filter-lift assay showing that LcrV
and PcrG interact (data not shown). To determine if PcrG
and LcrV also interacted in Y. pestis, we attempted to cop-
urify the two proteins from bacterial extracts. PcrG and
His6-LcrV were coexpressed in a Y. pestis strain with lcrG
and lcrV deleted and the cleared lysates were applied to a
Talon column. PcrG reacts weakly with antibody to LcrG,
allowing us to detect the presence of PcrG on immunob-
lots. PcrG was present in the elution fraction (Fig. 5A, lane
6), indicating that PcrG was retained on the Talon col-
umn. This result demonstrated that PcrG and LcrV interact
in Y. pestis. The interaction of PcrG with LcrV supports the
mutagenesis and sequence data indicating that residues
conserved between LcrG and PcrG are likely to be impor-
tant for interaction with LcrV.
Since PcrG and LcrV interacted in Y. pestis, the ability of
PcrG to complement an lcrG strain of Y. pestis was exam-
ined. Cultures of lcrG strains transcomplemented with ei-
ther LcrG or PcrG were grown in the presence and absence
of calcium and harvested after four hours of growth at
37°C. Culture supernatants were examined for the pres-
ence of secreted proteins by immunoblotting for LcrV,
YopE, and YopM. Fig. 5B shows that LcrG expression
blocked secretion in this strain in the presence of calcium
and allowed secretion in its absence (Fig. 5B, lanes 3 and
4). However, when PcrG was expressed, secretion was not
blocked in either the presence or absence of calcium (cal-
cium-blind phenotype) similar to the parent strain (Fig.
5B, lanes 5 and 6). Therefore, while PcrG is capable of in-
teracting with LcrV, it differs from LcrG in its ability to
block secretion of Yops in Y. pestis.
Table 1: Two hybrid analysis of alanine site-directed mutants of 
LcrG (residues 7–40) with LcrV.
Mutation Filter-lift Reaction β -galactosidase activitya
wildtype + 68.05 ± 2.96
LcrG aloneb -6 . 7 1   ± 0.51
T12A + 51.55 ± 5.15
L13A + 50.80 ± 5.13
K14A + 58.60 ± 2.57
E17A + 54.85 ± 6.19
L18A + 59.55 ± 0.95
I20A + 51.85 ± 3.75
D22A + 42.65 ± 0.85
S23A + 66.73 ± 1.80
D24A + 45.93 ± 3.91
R26A + 43.27 ± 2.67
K28A + 47.87 ± 3.43
L29A + 47.00 ± 2.99
L30A + 47.90 ± 3.30
E32A + 65.25 ± 4.85
M33A + 48.40 ± 3.00
C34A + 46.73 ± 2.00
I37A + 52.27 ± 2.23
aβ -galactosidase activity is expressed as Miller Units ± standard error 
of the mean. bThis value is derived from yeast expressing LcrG and an 
empty vector control.
Table 2: Two hybrid analysis of 'radical' site-directed mutants of 
LcrG (residues 7–40) with LcrV.
Mutation Filter-lift reaction β -galactosidase activitya
wildtype + 68.05 ± 2.96
LcrG aloneb -6 . 7 1   ± 0.51
Y9R + 83.09 ± 5.12
L13E + 55.10 ± 4.31
A16R - 4.45 ± 0.42
A16D - 4.07 ± 0.22
L18R + 66.03 ± 4.94
A19R + 86.61 ± 8.92
I20R + 36.44 ± 3.72
S23R + 14.30 ± 1.61
A27E + 21.99 ± 1.24
L30T + 53.72 ± 3.54
L30R - 1.91 ± 0.26
M33R + 52.42 ± 2.10
I37R + 35.66 ± 2.38
aβ -galactosidase activity is expressed as Miller Units ± standard error 
of the mean. bThis value is derived from yeast expressing LcrG and an 
empty vector control.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/16
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Selection of PcrG mutants that block secretion
PcrG of P. aeruginosa can interact with LcrV, but cannot
block secretion of Yops in Y. pestis (Fig. 5B). This result
suggested that mutagenesis of pcrG could be used to iso-
late PcrG mutants capable of blocking Yops secretion in Y.
pestis. This genetic screen allowed the isolation of PcrG
mutants that functioned in Y. pestis in a manner indistin-
guishable from LcrG (Fig. 5B, compare lanes 7 and 8 to
lanes 3 and 4). DNA sequencing of seven independent
isolates revealed the presence of a phenylalanine to leu-
cine change at position 42 of PcrG in all seven of the iso-
lates. This result suggests that a region of PcrG including
amino acid 42 is capable of interaction with Y. pestis secre-
tion components and suggests that the homologous LcrG
region is likely to be involved in LcrG's secretion-blocking
activity.
Analysis of the putative secretion-blocking region of LcrG
Change of residue 42 in PcrG from phenylalanine to leu-
cine made the PcrG sequence look more like that of LcrG.
That is, position 42 of PcrG became identical to the corre-
sponding LcrG residue (L39) (Fig. 2, boxed residues). This
information suggested that residue 39 of LcrG was an ide-
al candidate for site-directed mutagenesis to disrupt
LcrG's secretion blocking activity. Accordingly, the leucine
at position 39 in LcrG was mutated to both phenylalanine
and arginine. Surprisingly, neither mutant LcrG protein
L39F (data not shown) or L39R (Fig. 6B, lanes 5 and 6) ef-
fected LcrG function. Subsequent mutagenesis of the phe-
nylalanine at position 48 of LcrG to arginine resulted in
an LcrG mutant (F48R, blue asterisk in Fig. 2) that was de-
fective for secretion blocking activity (Fig. 6B, lanes 7 and
8). Mutation of F48 to either alanine or leucine had no ef-
fect on the function of those LcrG variants, suggesting that
the hydrophobic nature of F48 is important for LcrG func-
tion. The expression level of LcrG and LcrG F48R from our
plasmid constructs were also analyzed in whole cell ex-
tracts. LcrG F48R was expressed as well as wild type LcrG,
demonstrating that its inability to block secretion is not
due to a change in the expression or stability of the pro-
tein (Fig. 6A, lanes 3–4 and 7–8). An interesting point to
note is that when Skrzypek and Straley deleted residues
39–53 of LcrG (highlighted in blue in Fig. 2), they ob-
tained a mutant protein that did not block Yops secretion
[5]. The LcrG F48R mutant, like the ∆ 39–53 mutant, inter-
acts with LcrV (data not shown and [4]), demonstrating
that the protein likely folds in a native conformation. Ad-
ditionally, the mutant confirms previous work that the
two known LcrG functions (secretion blocking and LcrV
interaction) are genetically separable [5]. Further experi-
ments will more precisely delineate the region of LcrG re-
quired to block the type III secretion apparatus.
Conclusions
The interaction of LcrG with LcrV is a critical factor in con-
trolling the activity of the type III secretion system in Y.
pestis[20]. In order to gain a deeper understanding of this
critical interaction, we determined the region of LcrG re-
quired for interaction with LcrV. Results presented in this
study demonstrate that the smallest linear region of LcrG
required for interaction with LcrV is residues 7 to 40
(highlighted in yellow in Fig. 2). Interestingly, this region
is predicted to form a coiled-coil domain. We have identi-
fied several residues (indicated with red asterisks in Fig. 2)
within the interacting region of LcrG that contribute to the
interaction with LcrV. When residues 7 to 40 of the pro-
tein are analyzed with a helical wheel projection, these
three residues (A16, S23, and L30) appear to lie on one
face of an amphipathic helix (Fig. 3). The seven amino-
acid periodicity of the residues is consistent with a coiled-
coil protein motif. These data strongly suggest the LcrV-in-
teraction domain of LcrG is contained within an amphip-
athic coiled-coil domain. Additionally, we exploited the
inability of PcrG to block secretion in Y. pestis as a point
to start mapping the region of LcrG required for blocking
the type III secretion apparatus. We found that mutation
of residue 42 in PcrG (boxed in Fig. 2) allowed the protein
to function in Y. pestis. This information, coupled with a
previous observation that deletion of residues 39 to 53
Figure 3
Helical wheel projection of residues 14–31 of LcrG.
Residues 14 to 31 of LcrG are shown in a helical wheel pro-
jection created with the WheelApp applet;  [http://cti.itc.Vir-
ginia.EDU/~cmg/Demo/wheel/wheelApp.html]. Basic
residues are shown in pink, acidic residues in green, neutral
amino acids in blue, and hydrophobic amino acids in yellow.
Residues in LcrG that are critical for LcrV interaction are
designated with an asterisk.
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within LcrG (highlighted in blue in Fig. 2) abolished the
secretion-blocking activity [5], allowed us to identify ami-
no acid 48 as a residue (blue asterisk in Fig. 2) required to
block the activity of the Y. pestis type III secretion appara-
tus.
Materials and Methods
Bacterial strains, yeast strains, and growth conditions
Yersinia pestis, Pseudomonas aeruginosa, Escherichia coli, and
Saccharomyces cerevisiae strains used are listed in Table 3.
Y. pestis strains were grown in heart infusion broth or on
tryptose blood agar base medium (Difco Laboratories,
Detroit, MI) at 26°C for genetic manipulations. For phys-
iological studies, growth of Y. pestis was conducted in a de-
fined medium, TMH, as previously described [29]. E. coli
strains were grown in Luria-Bertani medium or agar [30]
at 37°C. When appropriate, bacteria were grown in the
presence of antibiotics, which were used at 50 µg/ml for
both carbenicillin and kanamycin.
DNA methods and plasmid construction
Plasmid DNA was isolated using a QiaPrep Spin kit (Qia-
gen, Inc., Studio City, CA). Cloning methods were essen-
tially as described previously [31]. PCR fragments were
purified using the QiaQuick PCR purification kit (Qia-
gen). Transformation of DNA into E. coli was accom-
plished by using commercially obtained competent cells
(Novagen, Madison, WI). Electroporation of DNA into Y.
pestis was done as described previously [32]. Gene ampli-
fication was performed with DeepVent (New England Bi-
olabs, Beverly, MA) or Taq (Eppendorf Scientific,
Westbury, NY) DNA polymerase in a Perkin-Elmer Gene-
Amp Model 2400 thermocycler (Applied Biosystems, Fos-
ter City, CA).
Figure 4
Copurification of LcrG variants with His6-tagged LcrV. Cells of Y. pestis KIM8-3002.8 (∆ lcrGV2) containing plasmids
pAra-HT-V and pAraG18K (lanes 1 to 3), pJM131 (LcrG S23R) (lanes 4 to 6), pJM99 (LcrG L30R) (lanes 7 to 9), or pJM89
(LcrG A16R) (lanes 10 to12) were grown in TMH with calcium and induced with 0.2% (wt/vol) arabinose prior to temperature
shift to 37°C. Cultures were harvested after 4 h of growth at 37°C, and cellular extracts were disintegrated using a French
press (20,000 lb/in2). Unbroken cells and large debris were removed by centrifugation (14,000 ×  g) for 10 min and the cleared
extracts (lanes 1, 4, 7, and 10) were applied to a Talon column. Proteins that did not bind were collected as the flowthrough
fraction (lanes 2, 5, 8, and 11). Proteins were eluted from the column with 50 mM imidazole and collected (lanes 3, 6, 9, and
12). All protein samples were resolved by SDS-PAGE in a 12.5% polyacrylamide gel after dilution in 2X SDS sample buffer and
analyzed by immunoblotting with α -LcrG and α -LcrV. Proteins were visualized by probing with alkaline phosphatase-conju-
gated secondary antibodies and developing with NBT-BCIP.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/16
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Figure 5
PcrG interacts with LcrV, but is incapable of blocking Yops secretion. (A) Cells of Y. pestis KIM8-3002.8 (∆  lcrGV2)
containing plasmids pAra-HT-V and pAraG18K (lanes 1 to 3) or pJM132 (lanes 4–6) were grown in TMH and harvested as
described for Fig. 4. The cleared cellular extracts (lanes 1 and 4) were applied to a Talon column and proteins that did not bind
were collected as the flowthrough fraction (lanes 2 and 5). Proteins were eluted from the column with 50 mM imidazole and
collected (lanes 3 and 6). Protein samples were resolved by SDS-PAGE in a 12.5% polyacrylamide gel and analyzed by immuno-
blotting with α -LcrG and α -LcrV. (B) Cells of Y. pestis KIM8-3002.8 (∆ lcrGV2) containing plasmids pBAD18-Kan (vector; lanes
1 and 2), pAraG18-K (+LcrG; lanes 3 and 4), pJM132 (+PcrG; lanes 5 and 6), and pJM133 (+PcrG F42L) were grown in TMH
with or without calcium. Arabinose was added to 0.2% (wt/vol) to each of the cultures immediately prior to temperature shift
to 37°C to induce the expression of LcrG, PcrG, or PcrG F42L from the plasmids. Cultures were harvested after 4 h of growth
at 37°C, and samples were fractionated into whole-cell and cell-free culture supernatants. Culture supernatant samples were
separated by SDS-PAGE in a 12.5% polyacrylamide gel and analyzed by immunoblotting with α -YopM, α -LcrV, and α -YopE.
Proteins were visualized by probing with alkaline phosphatase-conjugated secondary antibodies and developing with NBT-
BCIP.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/16
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Site-directed mutagenesis was performed with PfuTurbo
DNA polymerase (Stratagene, La Jolla, CA) using the
QuikChange Site-directed Mutagenesis Kit (Stratagene)
according to the manufacturer's instructions. Comple-
mentary oligonucleotides were designed to contain the
desired mutation, flanked by unmodified sequence to an-
neal to the same sequence on opposite strands of the tem-
plate plasmid. Oligonucleotide primers were synthesized
by MWG Biotech (High Point, NC). pACTG was used as
the template for all plasmids listed in Table 1 and Table 2.
pAraG18K was used as the template for pJM99, pJM131,
pJM143, and pJM144. All mutations were confirmed by
sequence analysis (MWG Biotech). The sequences of all
mutagenic oligonucleotides are available upon request.
Plasmids used in this study are described in Table 3. All
plasmids expressing truncations of LcrG (pJM1, pJM2,
pJM3, pJM4, pJM5, pJM23, pJM52, and pJM53) were con-
structed by cloning BamHI- and NcoI-cleaved PCR prod-
ucts into pACT2. pJM110 was constructed by cloning a
BamHI- and NcoI-cleaved PCR product of pcrG into
pACT2. Plasmid pJM127 was constructed by cloning an
EcoRI-cleaved PCR p6roduct of pcrG into EcoRI- and SmaI-
cleaved pBAD18. pJM127 was digested with EcoRI and
XbaI to release a pcrG fragment that was subsequently sub-
cloned into EcoRI- and XbaI-cleaved pBAD18-Kan to cre-
ate pJM132. The sequences of all oligonucleotide primers
are available upon request.
To facilitate the selection of PcrG variants that functioned
to block Yops secretion (see below), the virulence plas-
mid, pCD1, of the lcrG Y. pestis strain KIM8-3002.7 was
tagged with a kanamycin resistance cassette to select for its
presence. pCD1 in KIM8-3002.7 was tagged with the
mini-Tn5 derived transposon EZ::Tn™ <R6Kγ ori/KAN-2>
(Epicentre Technologies, Madison WI) according to the
manufacturer's instructions to obtain KIM8-3002.7.MN1.
Location of the insertion was not determined but the LCR
phenotype and ability to translocate Yops into HeLa cells
was verified (data not shown).
Yeast two-hybrid assays
Yeast two-hybrid assays were performed as recommended
by the commercial supplier (Clontech, Palo Alto, CA).
Vectors pAS2-1 (encoding the GAL4 DNA binding do-
main) and pACT2 (encoding the GAL4 activation do-
main) were obtained from Clontech Laboratories as part
of the Matchmaker Two-Hybrid System 2 Kit. Plasmids
Figure 6
Identification of an LcrG residue required for secretion blocking activity. Cells of Y. pestis KIM8-3002.8 (∆ lcrGV2)
containing plasmids pBAD18-Kan (vector; lanes 1 and 2), pAraG18-K (+LcrG; lanes 3 and 4), pJM143 (+L39R; lanes 5 and 6),
and pJM144 (+F48R; lanes 7 and 8) were grown in TMH with or without calcium. Arabinose was added at 0.2% (wt/vol) to each
of the cultures immediately prior to temperature shift to 37°C to induce the expression of the LcrG variants from the plas-
mids. Cultures were harvested after 4 h of growth at 37°C, and samples were fractionated into whole-cell (A) and cell-free cul-
ture supernatants (B). Samples were separated by SDS-PAGE in a 12.5% polyacrylamide gel and analyzed by immunoblotting
with α -YopM, α -LcrV, α -YopN, α -YopD, α -YopE, and α -LcrG. Proteins were visualized by probing with alkaline phosphatase-
conjugated secondary antibodies and developing with NBT-BCIP.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/16
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were transformed into Saccharomyces cerevisiae strain Y187
by using the Frozen-EZ Yeast Transformation II kit (Zymo
research, Orange, CA) and plated on appropriate minimal
yeast synthetic-dropout medium plates. Colony filter-lift
assays to detect β -galactosidase activity were performed as
described by Clontech laboratories. Liquid β -galactosi-
dase assays were performed using the Yeast β -galactosi-
dase Assay Kit (Pierce, Rockford, IL) according to the
manufacturer's instructions. β -galactosidase units were
calculated as described previously [30].
PcrG selection
Error-prone PCR was used to mutagenize pcrG for selec-
tion of PcrG variants that could block Yops secretion in an
lcrG background (KIM8-3002.7.MN1). Mutazyme (Strata-
gene, La Jolla, CA) was used to amplify PcrG for cloning
into pBAD18 [33]. The ligation reaction was electroporat-
ed into lcrG Y. pestis (which is temperature sensitive due to
its Ca2+-blind phenotype) and the cells were plated on
TMH medium [29] containing arabinose, Ca2+, kanamy-
cin and carbenicillin. Transformants that grew at 37°C
were streak purified and checked for phenotype by deter-
Table 3: Strains and plasmids used in this studya.
Strain or plasmid Relevant properties Source or reference
E. coli
Novablue recA1 endA1 hsdR17 (rK
- mK
+) supE44 thi-1 gyrA96 relA1 lac [F' 
proA+B+lacIqZ∆ M15::Tn10]
Novagen
P. aeruginosa
PAO1 Wild-type strain K. Young
Y. pestis
KIM8-3002.7 KIM8-3002 ∆ lcrG3 [38]
KIM8-3002.8 KIM8-3002 ∆ lcrGV2 [20]
KIM8-3002.7.MN1 KIM8-3002.7 pCD1::Tn<R6Kγ ori/KAN-2> This study
Saccharomyces cerevisiae
Y187 MATa ura3-52 his3-200 ade2-101 trp1-901 leu2-3 112 gal4∆ met gal80∆ URA3::GAL1UAS-
GAL1TATA-lacZ
Clontech
Plasmidsa
pACT2 GAL4(768–881) AD LEU2 Apr Clontech
pACTG pACT2 + lcrG [20]
pAS2-1 GAL4(1–147) DNA-BD TRP1 AprCYHS2 Clontech
pJM17 pAS2-1 ∆ cyh2 [20]
pASV pAS2-1 + lcrV [20]
pJM15 pASV ∆ cyh2 [20]
pJM1 pACT2 + lcrG' 1–40b This study
pJM2 pACT2 + lcrG' 34–70b This study
pJM3 pACT2 + lcrG' 64–95b This study
pJM4 pACT2 + lcrG' 1–70b This study
pJM5 pACT2 + lcrG' 34–95b This study
pJM23 pACT2 + lcrG' 1–33b This study
pJM52 pACT2 + lcrG' 7–40b This study
pJM53 pACT2 + lcrG' 12–40b This study
pBAD18-Kan araBADp cloning vector, Kmr [33]
pAraG18K pBAD18-Kan + lcrG [4]
pAra-HT-V pBAD24 + His6-LcrV, Apr [20]
pJM89 pBAD18-Kan + lcrG (A16R)c [20]
pJM99 pBAD18-Kan + lcrG (L30R)c This study
pJM131 pBAD18-Kan + lcrG (S23R)c This study
pJM110 pACT2 + pcrG This study
pJM127 pBAD18 + pcrG This study
pJM132 pBAD18-Kan + pcrG This study
pJM133 pBAD18 + pcrG (F42L)c This study
pJM143 pBAD18-Kan + lcrG (L39R)c This study
pJM144 PBAD18-Kan + lcrG (F48R)c This study
a Numerous plasmids used for two hybrid analysis of LcrG site-directed mutants are not listed here to conserve space. All plasmids are available 
upon request. b Amino acids of LcrG included in the construct are indicated. c Amino acid substitutions are indicated.BMC Microbiology 2002, 2 http://www.biomedcentral.com/1471-2180/2/16
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mining Ca2+-dependence, which suggests restoration of
"LcrG function" by PcrG. Ca2+-dependent strains were
subsequently used for plasmid isolation. Isolated plas-
mids were re-electroporated into an unmutagenized back-
ground and the strains were re-evaluated for growth at
37°C and secretion of Yops.
Cell fractionation and affinity purification
Bacterial cells were fractionated as previously described
[18]. Briefly, bacterial cells were chilled on ice after
growth, harvested by centrifugation, and washed in cold
phosphate-buffered saline (PBS; [34]). Bacterial whole
cell fractions were prepared by resuspending the washed
cells in cold PBS and precipitating total proteins with 10%
(vol/vol) trichloroacetic acid (TCA) on ice overnight. Se-
creted proteins were recovered from the bacterial growth
medium by centrifuging the spent medium a second time,
transferring the supernatant to a clean tube, and precipi-
tating with 10% (vol/vol) TCA on ice overnight. The TCA-
precipitated proteins were pelleted by centrifugation
(20,800 ×  g at 4°C) for 20 min and resuspended in 2X so-
dium dodecyl sulfate (SDS) sample buffer [34]. Protein
extracts for affinity-purification were prepared by disinte-
gration with a French press. Ice-cold yersiniae were resus-
pended in ice-cold PBS and passed through a French
pressure cell at 20,000 psi. Following disintegration, the
extracts were clarified by centrifugation at 20,800 ×  g for
10 min at 4°C. Affinity purification with His6-LcrV was
performed using Talon resin (Clontech) as described by
the manufacturer.
Protein electrophoresis and immunodetection
Proteins were separated by SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE), using 12.5 % (wt/vol) polyacry-
lamide gels according to the method of Laemmli [35].
Samples were boiled 3–5 min before loading on the gels.
Samples were loaded such that lanes containing different
culture fractions represented equivalent amounts of the
original cultures. Proteins resolved by SDS-PAGE were
transferred to Immobilon-P membranes (Millipore Corp.,
Bedford, MA) using carbonate transfer buffer (pH 9.9) [5].
Specific proteins were visualized using rabbit polyclonal
antibodies specific for glutathione S-transferase (GST)-
tagged LcrG (α -LcrG) [4], His-tagged LcrV (α -LcrV) [4],
YopM (α -YopM) [36], GST-tagged LcrQ (α -LcrQ) [16],
YopN (aka LcrE) (α -LcrE [4]), His-tagged YopD (α -YopD)
[16], and YopE (α -YopE; gift from S. C. Straley, University
of Kentucky, Lexington, KY. Alkaline phosphatase-conju-
gated secondary antibody (goat anti-rabbit immunoglob-
ulin G; Pierce) was used to visualize proteins by
development with nitroblue tetrazolium and 5-bromo-4-
chloro-3-indolylphosphate (NBT-BCIP; Fisher Scientific,
Fair Lawn, NJ).
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